Introduction
The recording of somatosensory evoked potentials (SEPs) and evoked magnetic fields (SEFs) has been common practice for the assessment of the functional integrity of the human somatosensory system [1] [2] [3] [4] [5] . Clinically, SEP/SEF applications are varied, including the measurement of nerve conduction velocity abnormalities in the setting of white matter lesions (e.g., evoked-response latencies are known to be delayed in multiple sclerosis) [6] , identifying the central sulcus in patients in need of pre-surgical functional mapping [7] , and to monitor the integrity of afferent somatosensory pathways [8] . SEPs/SEFs are typically elicited by electrical stimuli applied to a peripheral nerve, such as stimulation of the median nerve at the wrist. Electrical median nerve stimulation produces strongly synchronized afferent responses by simultaneously activating a large number of mixed (i.e., both sensory and motor) nerve fibers governing the palmar thumb, index and middle fingers, and with contributions from a mixture of different kinds of afferent fibers (e.g., cutaneous mechanoreceptors, joint, and muscle spindle afferents). Median nerve stimulation produces a sequence of deflections in the averaged evoked response, whose neural origins have been localized to primary somatosensory cortex (SI) using equivalent current dipole (ECD) modeling [4, [9] [10] [11] [12] [13] [14] . The first cortical response following median nerve stimulation peaks at about 20 milliseconds (ms) and has been termed the "MNN20" using electroencephalography (EEG), or "MNN20m" using magnetoencephalography (MEG). ECD source orientation of the MNN20m Electrical median nerve stimulation can be unpleasant, even painful, thus challenging for use with clinical pediatric populations. Alternatively, a variety of more natural tactile stimulation methods
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A C C E P T E D M A N U S C R I P T 4 have been developed for studying the somatosensory responses: tactile tapping [16] , brushing [17, 18] , vibration [19] , air puff [20] [21] [22] as well passive movement [23, 24] . Tactile stimuli can be applied to any discrete area of the skin (e.g., fingers, lips, toes, etc.) and as such, these responses have also been used to detail the somatotopic representations of the human somatosensory cortex non-invasively with MEG [25, 26] . Not surprisingly, transient mechanical stimulation of an individual fingertip, for example, tends to evoke similar response waveforms as median nerve stimulation. However, due to relatively slower nerve conduction velocities, responses to transient mechanical stimulation occur with slightly longer evoked-response latencies than those produced using median nerve stimulation [15] . Like the 
A C C E P T E D M A N U S C R I P T 5 neurodevelopmental disorder Angelman syndrome, a disorder most commonly caused by deletion of a segment of the maternally inherited chromosome 15q11-q13 region, which includes GABAA receptor subunit genes, and results in disrupted GABAA signaling [30] . The MNP35m component magnitude has also been shown to diminish in amplitude with increasing stimulation frequency, a feature similar to that observed with postsynaptic IPSPs [31, 32] . The MNP35 is also rapidly reduced at the beginning of a 10 Hz stimulus train [14] similar to the response from parvalbumin-containing inhibitory interneurons in primary somatosensory (SI) cortex [33] [34] [35] . Unlike the MNN20m, the MNP35m has also been shown to be sensitive to on-going movement of the fingers, increasing with ipsilateral finger movement and decreasing with contralateral finger movement [14] . Finally, unlike the tactile N30m, the tactile P50m is absent in newborns and begins to emerge after about 18 months [15] , possibly in relation to the known developmental change in GABAA signaling from predominantly excitatory to inhibitory, due to changing intracellular chloride (Cl -) concentrations [36, 37] .
Given the evidence that these post-excitatory MNP35m or tactile P50m components may serve as indices of inhibitory signaling, it may be of interest to investigate these responses in clinical populations where cortical inhibition is thought to be impaired. Epilepsy, for example, is a diverse collection of neurological disorders characterized by sudden recurrent episodes of sensory disturbance, loss of consciousness, or convulsions, associated with abnormal synchronous electrical activity in the brain, and is generally thought to be the consequence of an imbalance between inhibitory and excitatory signaling [38, 39] . Early demonstrations have shown that direct injection of GABA receptor antagonists (e.g., bicuculline, penicillin, pictotoxin) or glutamate receptor agonists (e.g., N-methyl-D-aspartate, NMDA) can trigger limbic motor seizures in rats and non-human primates [40] [41] [42] [43] [44] . Since then, considerable research has taken place to identify medications that potentiate cortical GABA levels (e.g., vigabatrin
and tiagabine). It should also be noted that, whereas there is general agreement that GABA and glutamate signaling are involved in seizure generation, the relationship is complex: in some cases,
A C C E P T E D M A N U S C R I P T 6 increasing GABA levels actually promotes seizures [45] [46] [47] [48] , and medications acting on GABA and glutamate levels are far from perfectly effective in treating seizure disorders.
Another clinical population where impaired GABAergic signaling has been implicated is Autism Spectrum Disorder (ASD). ASD represents a distinct group of complex disorders of brain development Somatosensory responses in patients with epilepsy have not been explored to the same degree as in ASD, and far less is known about whether the evoked response to tactile stimulation is atypical in children with epilepsy. However, it does appear that SEP latency and amplitude differences in epilepsy may depend on the type of epilepsy under evaluation. For example, using median nerve stimuli, Salas-Puig et al., (1992) compared SEPs between patients with juvenile myoclonic epilepsy (JME), idiopathic generalized epilepsy (IGE), and controls [66] . The authors reported that the N19-P25 interval was significantly prolonged in the IGE group both as compared with the JME and control groups, but that no amplitude differences were noted between groups for the N19 component. However the P25 and N33
amplitudes were significantly higher in the JME group, including "giant SEPs" in 14% of JME patients [66] . Another additional consideration is the use of anti-seizure medication in patients with epilepsy.
While limited to case studies, there is some evidence that anti-epileptic medications such as phenytoin may increase SEP latency [66] whereas valproic acid may decrease SEP amplitudes [67] .
The aim of the present study was to compare tactile P50m responses from a group of children with epilepsy and a group of children with ASD, with age matched TD controls. Given the evidence that 1) the tactile P50m response may represent GABA dependent post-excitatory inhibition and 2) GABA signaling is thought to be downregulated in both epilepsy and ASD, we hypothesized that separately, for both children with epilepsy and children with ASD, we would observe decreased SEF P50m response amplitudes to tactile stimulation of the digits. Whereas there is considerable support for auditory response latency differences of the N100m component between children with ASD and TD [68] [69] [70] , we have no direct evidence supporting a hypothesis of delayed latencies in the SEF tactile P50m peak response between ASD, TD and epilepsy groups.
Material and Methods

Participants
The Communication Questionnaire (SCQ [73] ). Dimensional symptom severity ratings were obtained by parent report on the Social Responsiveness Scale-2 nd Ed. (SRS-2 [74] ) and by direct measurement using the ADOS-2 severity score metric [75] . The parent-completed Autism Diagnostic Interview-Revised (ADI-R) was administered for all participants who entered the study without a formal ASD diagnosis made by an expert clinician (e.g., ASD educational classification only) and for any child with a prior ASD diagnosis for whom a diagnostic discordance existed (e.g. a child who exceeded ADOS diagnostic cut-offs but was below SCQ and SRS-2 cut-offs). For final inclusion in the ASD group, children exceeded established cutoffs on the ADOS-2 and either the SCQ or SRS-2. Children 1 point below ADOS cut-offs were included in the ASD group if they exceeded cut-offs on at least two ASD parent-report questionnaires or on the ADI-R. Children without a prior diagnosis made by an expert clinician were required to exceed diagnostic cutoffs on both the ADOS-2 and ADI-R.
TD Inclusion Criteria: For this study, fifteen 8 to 12-year-old TD children (mean age 10.21 ± 1.61 (SD) years; 2 female) were recruited through pediatric practices of the CHOP primary care network. TDspecific inclusion criteria included scoring below the cut-off for ASD on the ADOS-2 as well as parent questionnaires, and performance above the 16 th percentile on an index of language ability, the Clinical Evaluation of Language Fundamentals-4 th or 5 th Editions (CELF-4 or CELF-5) [76] . Additional TD-specific exclusion/inclusion criteria included no history of psychiatric disorders and no developmental disorders or first-degree relatives with ASD. TD children were age and gender matched to the ASD group.
Additional Inclusion/Exclusion Criteria for ASD and TD: All subjects were native English speakers with no known genetic syndromes, neurological disorders (e.g. epilepsy, cerebral palsy, traumatic brain injury (TBI)) or sensory impairments (somatosensory, hearing, visual). To rule out global cognitive delay, all participants also scored at or above the 5 th percentile (SS>70) on indices of nonverbal intelligence on the Wechsler Intelligence Scale for Children-4 th or 5 th Editions (WISC-IV or WISC-V [77] ).
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A and then filtered between 1-40Hz and the DC offset was removed using the pre-trigger 100ms time period. Following this procedure, no differences in head motion were observed between groups, and no group differences existed in the number of trials per average (paired t-tests all > p=0.05). Independently for both dipole moment and latency, we assessed effects of diagnostic group using a linear mixed model (LMM) with subject as a random effect and group and hemisphere as fixed effects and age as a covariate (a full factorial design was employed, including both 2-and 3-way interactions between group, hemisphere and age).
Equivalent Current Dipole (ECD) Analysis
To ensure effects determined using the tests above were not secondary to systematic source localization or orientation biases, we conducted post-hoc assessment of effect of group on any of the three coordinates of source localization, or of source orientation in analogous independent LMM's.
Note, for the y-coordinate of source localization (left-right axis), we conducted separate LMM's for left and right digit stimulation.
Results
Participant Characteristics
The enrolled cohorts consisted of 15 TD, 15 ASD, and 17 EPI participants. Clinical characteristics are summarized in Tables 1, 2 Table 3 ).
Figure 1.
MEG averaged response waveforms from left index finger stimulation for three representative subjects (TD, ASD, and Epilepsy) is shown. Left: Vertical black line denotes tactile P50m peak and is scaled to the height of the TD response. Middle: tactile P50m field topography shows the dipolar field patterns for each tactile P50m peak response. Right: Coregistered ECD dipole locations for each tactile P50m responses are localized to contralateral primary somatosensory cortex for each subject. Note the larger amplitude in TD and the delayed response in epilepsy.
Dipole Moment
A linear mixed model (LMM) was performed on dipole moment, with subject as a random effect and group and hemisphere as fixed effects and age as a covariate (a full factorial design was employed, including both 2-and 3-way interactions between group, hemisphere and age). The choice to use 
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15 Furthermore, within the epilepsy cohort, there was no significant difference in lesional vs. non-lesional cases (considering the potential main effect of "lesion" in an equivalent LMM applied to the epilepsy cohort) with marginal means (age 10.57years): non-lesional 61.8±7.4ms, lesional 59.8±12.8ms, F(1,25)=0.407, p=0.533).
Figure 2a
. Group mean and standard deviations for dipole moment reveal a significant overall effect of group F(2,41)=4.21, p<0.05. Independent post-hoc pair wise comparisons showed means were significantly different TD (21.3±7.0nAm(SD)) vs epilepsy (14.7±6.6nAm), p<0.02 and TD vs ASD (15.4±7.4nAm).
Figure 2b
. Group mean and standard deviations for dipole peak latency: Significant overall effect of group F(2,41)=12.0, p<0.05. Post-hoc pair wise comparisons showed this to be driven by a latency delay of ~6ms in the epilepsy group: means were significantly different TD (55.8±5.4ms) vs epilepsy (61.6ms±5.0ms), p<0.02, but not significant for TD vs ASD (52.4±5.4ms), p=0.9.
Post-hoc assessment of effect of group on any of the three coordinates of source localization, or of source orientation in independent LMM's showed no significant effect of Group on any source localization parameter (all p's>0.4), eliminating the possible influence of source localization bias on the above estimates of moment and latency effects.
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Discussion
The aim of the current study was to assess whether the somatosensory tactile P50m response in children with ASD and children with epilepsy was reduced compared to TD controls. We hypothesized that the magnitude of the tactile P50m somatosensory response would be reduced in both patient groups, possibly due to reduced GABAergic signaling as has been implicated in a variety of previous animal models and in vivo human MRS studies. We observed significant (~25%) decreases in tactile P50m dipole moment values, both for children with epilepsy and for children with ASD. In addition, the latency of the tactile P50m peak was observed to be not different between TD and ASD groups but was significantly delayed in children with epilepsy by ~6ms.
The observed decrease in dipole moment in both the ASD and epilepsy patient groups is consistent with the model of reduced GABAergic signaling in the brains of these clinical populations.
Direct support for downregulation of somatosensory GABA signaling in children with ASD comes from . While these data generally support a global deficit in cortical response amplitudes across all sensory modalities in children with ASD they are also distinct from the well-known finding of a delayed N100m auditory response consistently observed in these children [68] [69] [70] .
We observed an ~6ms delay in tactile P50m somatosensory response in our epilepsy participants which has not been reported previously. A prolonged N19-P25 interval has, however been reported in patients with idiopathic generalized epilepsy (IGE) using median nerve stimulation [66] . Both visual [86] and auditory delays [87] have been observed in the evoked responses of adults and children with epilepsy. We speculate that the influence of anti-epileptic medications may be a contributing factor in promoting the tactile P50m latency delay in our epilepsy group (see Table 3 ). However, evidence does exist where median nerve P25 somatosensory response amplitude (but not latency) was reported to be reduced following valproate (i.e., Depakote) administration [67] . In the current study, only 2 of our
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19 patients were taking Depakote at the time of study and thus did not likely bias the observed group effects of decreased moment and increased latency in the epilepsy group (see Table 3 ).
There are, however, additional factors that could also have contributed to the observed latency delay and reduced ECD moment in our epilepsy patients. One such factor is the potential reorganization As in any neurophysiologic studies of patients with epilepsy, disentangling the effects of the underlying disorder from the effects of anti-seizure medications with widely varying mechanisms of action is difficult. The sample size of the cohort in this study is under powered to make comparisons between medications or mechanism of action categories. An additional complicating factor may also be the natural fluctuations in cortical excitability related to peri-ictal or interictal states in patients with epilepsy. Future studies within more homogeneous epilepsy populations may enable further delineation of the many factors potentially contributing to the findings observed here. Similarly, the lack of statistical power reduces our ability to make inferences about differential effects in lesional vs nonlesional cases. In the analyses performed no significant differences were found in moment or latency, but this should be interpreted with caution given the rather few lesional cases (see Table 3 ).
One novel aspect of the current study was the observation of significantly reduced P50m To better identify shared mechanisms between epilepsy and ASD, it is becoming increasingly common to investigate genetic disorders for which both epilepsy and ASD commonly occur, such as Of course, there are multiple genetic and environmental causes for both ASD and epilepsy, but both have been conceptualized as disorders of aberrant E/I ratio via reduced inhibitory signaling which may possibly be explained by the same early insult. For example, a specific genetic mutation may impair the promotion of inhibitory signaling in the cortex, and thus disrupt the E/I balance. This disruption may then promote early life seizure activity resulting in seizures or devastating impairments in social communication and behavior, or both. The current study lends additional support for the theory that GABA signaling is downregulated both in the brains of children with ASD and in children with epilepsy.
To better understand the relationship between GABA, cortical signaling and behavior, further work is needed to replicate our current findings in clearly stratified groups (EPI only; ASD only) as well as a comorbid group (ASD+EPI) and directly relate them to both in vivo measures of GABA via, e.g. MRS
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